TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
TCL Archive DRCCA Board Okays Concepts Of New Cooperative Agreements For Smoking Program, Flow Cytometry For Bladder Cancer October 28, 1983
TCL Archive DCT Board Approves Concept Of Contract Recompetitions Worth $5.1 Million A Year July 10, 1981
